No increased risk for cancer seen with ranitidine vs famotidine

There was no evidence of increased risk for various cancers among patients who used ranitidine compared with those who used famotidine; however, ranitidine users compared with the general population were more likely to have a cancer diagnosis and other risk factors for cancer, according to data from Digestive Disease Week.“Although the results are reassuring, they need to be interpreted with caution, given this is a retrospective study and further studies would be needed to definitively answer the question,” Nabeeha Mohy-ud-din, MD, internal medicine resident, Allegheny HealthRead More

Share on facebook
Share on twitter
Share on linkedin